Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis |
Kokcu, Arif
(Department of Obstetrics and Gynecology, Ondokuz Mayis University)
Kurtoglu, Emel (Department of Obstetrics and Gynecology, Ondokuz Mayis University) Celik, Handan (Department of Obstetrics and Gynecology, Ondokuz Mayis University) Kefeli, Mehmet (Department of Pathology, Ondokuz Mayis University) Tosun, Migraci (Department of Obstetrics and Gynecology, Ondokuz Mayis University) Onal, Mesut (Department of Obstetrics and Gynecology, Ondokuz Mayis University) |
1 | Goudge C, Bernhard S, Cloven NG, Morris P (2004). The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer. Gynecol Oncol, 93, 536-9. DOI |
2 | Havrilesky LJ, Cragun JM, Calingaert B, et al (2005). Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol, 99, 689-95. DOI |
3 | Hidaka T, Kato K, Yonezawa R, et al (2007). Omission of lymphadenectomy is possible for low-risk corpus cancer. Eur J Surg Oncol, 33, 86-90. DOI |
4 | Hidaka T, Nakashima A, Shima T, Hasegawa T, Saito S (2010). Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer. Obstet Gynecol Int, 2010, 490219. |
5 | Homesley HD, Kadar N, Barrett RJ, Lentz SS (1992). Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol, 167, 1225-30. DOI |
6 | Kang WD, Kim CH, Cho MK, et al (2009). Lymphadenectomy for low-risk endometrial cancer based on preoperative and intraoperative assessments. Int J Gynecol Cancer, 19, 657-61. DOI |
7 | Kumar S, Mariani A, Bakkum-Gamez JN, et al (2013). Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol, 130, 441-5. DOI |
8 | Larson DM, Johnson KK (1993). Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium. Gynecol Oncol, 51, 345-8. DOI |
9 | Mariani A, Webb MJ, Keeney GL, et al (2000). Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol, 182, 1506-19. DOI |
10 | May K, Bryant A, Dickinson HO, Kehoe S, Morrison J (2010). Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev, 20, CD007585. |
11 | NCCN clinical Practice Guidelines in Oncology databases. Uterine neoplasms V.1.2011 (http://www.nccn.org). |
12 | Pecorelli S (2009). Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet, 105, 103-4. DOI |
13 | Sethasathien P, Charoenkwan K, Siriaunkgul S (2014). Accuracy of intraoperative gross examination of myometrial invasion in stage I-II endometrial cancer. Asian Pac J Cancer Prev, 15, 7061-4. DOI |
14 | Singh M, Zaino RJ, Filiaci VJ, Leslie KK (2007). Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol, 106, 325-33. DOI |
15 | Todo Y, Kato H, Kaneuchi M, et al (2010). Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet, 375, 1165-72. DOI |
16 | Wang ZQ, Wang JL, Shen DH, Li XP, Wei LH (2013). Should all endometrioid uterine cancer patients undergo systemic lymphadenectomy? Eur J Surg Oncol, 39, 344-9. DOI |
17 | Vargas R, Rauh-Hain JA, Clemmer J, et al (2014). Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol, 133, 216-20. DOI |
18 | Zhang C, Wang C, Feng W (2012). Clinicopathological risk factors for pelvic lymph node metastasis in clinical earlystage endometrioid endometrial adenocarcinoma. Int J Gynecol Cancer, 22, 1373-7. DOI ScienceOn |
19 | Akbayir O, Corbacioglu A, Goksedef BP, et al (2012). The in endometrioid adenocarcinoma of endometrium. Gynecol Oncol, 125, 400-3. DOI ScienceOn |
20 | Abu-Rustum NR, Alektiar K, Iasonos A, et al (2006). The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at memorial sloan-kettering cancer center. Gynecol Oncol, 103, 714-8. DOI |
21 | ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009). Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet, 373, 125-36. DOI |
22 | Ayhan A, Yarali H, Urman B, et al (1989) Lymph node metastasis in early endometrium cancer. Aust N Z J Obstet Gynaecol, 29, 332-5. DOI |
23 | Bassarak N, Blankenstein T, Bruning A, et al (2010). Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium? BMC Cancer, 10, 224. DOI |
24 | Bell JG, Patterson DM, Klima J, et al (2014). Outcomes of patients with low-risk endometrial cancer surgically staged without lymphadenectomy based on intra-operative evaluation. Gynecol Oncol, 134, 505-9. DOI |
25 | Ben-Shachar I, Pavelka J, Cohn DE, et al (2005). Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol, 105, 487-93. DOI |
26 | De Wilde RL, Rafei A, Herrmann A (2014). Can a lymphadenectomy be avoided in early-stage endometrial adenocarcinoma? Arch Gynecol Obstet, 290, 973-8. DOI |
27 | Benedetti Panici P, Basile S, Maneschi F, et al (2008). Systematic pelvic lymphadenectomy vs. no lymphadenectomy in earlystage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst, 100, 1707-16. DOI |
28 | Chan JK, Cheung MK, Huh WK, et al (2006). Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer, 107, 1823-30. DOI |
29 | Chan JK, Wu H, Cheung MK, et al (2007). The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol, 106, 282-8. DOI |
30 | Dowdy SC, Borah BJ, Bakkum-Gamez JN, et al (2012). Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol, 127, 5-10. DOI ScienceOn |
31 | Eltabbakh GH, Piver MS, Hempling RE, Shin KH (1997). Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys, 38, 373-80. DOI |
32 | Ferlay J, Soerjomataram I, Ervik M, et al GLOBOCAN (2012) v1.0 databases Cancer Incidence and Mortality Worldwide (http://globocan.iarc.fr). |
33 | Fotiou S, Trimble EL, Papakonstantinou K, et al (2009). Complete pelvic lymphadenectomy in patients with clinical early, grade I and II endometrioid corpus cancer. Anticancer Res, 29, 2781-5. |
![]() |